P. Tamma
Critical Care and Intensive Care Medicine · 2012–2024
A researcher in the Science corpus: 4 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Critical Care and Intensive Care Medicine — 14 citations into it
- Applied Microbiology and Biotechnology — 10 citations into it
- Clinical Biochemistry — 5 citations into it
Whom P. Tamma trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from P. Tamma's perspective
Ordered by how strongly the researchers P. Tamma trusts endorse each paper. Same corpus, a different order for every researcher.
- The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. (Chest)
- Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. (American Journal of Medicine)
- Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use. (Journal of the American Medical Association (JAMA))
- Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. (Clinical Infectious Diseases)
- Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. (Clinical Infectious Diseases)
- Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome. (Clinical Infectious Diseases)
- Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis* (Critical Care Medicine)
- Trends in antimicrobial drug development: implications for the future. (Clinical Infectious Diseases)
- Global Challenge of Multidrug-Resistant Acinetobacter baumannii (Antimicrobial Agents and Chemotherapy)
- Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. (Clinical Infectious Diseases)
Their papers
- Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. (2024) — 912 citations
- Infectious Diseases Society of America Antimicrobial Resistant Treatment Guidance: Gram-Negative Bacterial Infections. (2020) — 636 citations
- Association of Adverse Events With Antibiotic Use in Hospitalized Patients (2017) — 677 citations
- Combination Therapy for Treatment of Infections with Gram-Negative Bacteria (2012) — 727 citations